{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T13:51:39Z","timestamp":1788961899335,"version":"build-2803163510"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T00:00:00Z","timestamp":1760745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T00:00:00Z","timestamp":1760745600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Childs Nerv Syst"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s00381-025-06981-4","type":"journal-article","created":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T13:58:53Z","timestamp":1760795933000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The effect of oncolytic virotherapy on pediatric brain tumor- a systematic review"],"prefix":"10.1007","volume":"41","author":[{"given":"Praveen Nandha Kumar Pitchan","family":"Velammal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thirumalaivasan","family":"Dhasakeerthi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan Roy","family":"Varghese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mansi","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keerthana","family":"Veluswami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hari Vorappan","family":"Manickavelan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gurunathan","family":"Srinivasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,18]]},"reference":[{"issue":"2","key":"6981_CR1","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/BF00307927","volume":"6","author":"S Oi","year":"1990","unstructured":"Oi S, Kokunai T, Matsumoto S (1990) Congenital brain tumors in Japan (ISPN cooperative study): specific clinical features in neonates. Childs Nerv Syst 6(2):86\u201391","journal-title":"Childs Nerv Syst"},{"issue":"Suppl 5","key":"6981_CR2","doi-asserted-by":"publisher","first-page":"v1","DOI":"10.1093\/neuonc\/noac202","volume":"24","author":"QT Ostrom","year":"2022","unstructured":"Ostrom QT, Price M, Neff C, Cioffi G, Waite KA, Kruchko C, Barnholtz-Sloan JS (2022) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2015\u20132019. Neuro Oncol 24(Suppl 5):v1\u2013v95. https:\/\/doi.org\/10.1093\/neuonc\/noac202","journal-title":"Neuro Oncol"},{"issue":"10","key":"6981_CR3","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1177\/0883073808321768","volume":"23","author":"F Nejat","year":"2008","unstructured":"Nejat F, El Khashab M, Rutka JT (2008) Initial management of childhood brain tumors: neurosurgical considerations. J Child Neurol 23(10):1136\u20131148. https:\/\/doi.org\/10.1177\/0883073808321768","journal-title":"J Child Neurol"},{"key":"6981_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/genes13040624","volume":"13","author":"AM Buccoliero","year":"2022","unstructured":"Buccoliero AM, Giunti L, Moscardi S, Castiglione F, Provenzano A, Sardi I, Scagnet M, Genitori L, Caporalini C (2022) Pediatric high grade glioma classification criteria and molecular features of a case series. Genes (Basel) 13:624. https:\/\/doi.org\/10.3390\/genes13040624","journal-title":"Genes (Basel)"},{"issue":"8","key":"6981_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/v15081645","volume":"15","author":"P Muthukutty","year":"2023","unstructured":"Muthukutty P, Yoo SY (2023) Oncolytic virus engineering and utilizations: cancer immunotherapy perspective. Viruses 15(8):1645. https:\/\/doi.org\/10.3390\/v15081645","journal-title":"Viruses"},{"issue":"2","key":"6981_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/diseases6020042","volume":"6","author":"K Lundstrom","year":"2018","unstructured":"Lundstrom K (2018) Viral vectors in gene therapy. Dis 6(2):42. https:\/\/doi.org\/10.3390\/diseases6020042","journal-title":"Dis"},{"issue":"1","key":"6981_CR7","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1097\/PPO.0b013e31824671c9","volume":"18","author":"G Wollmann","year":"2012","unstructured":"Wollmann G, Ozduman K, van den Pol AN (2012) Oncolytic virus therapy for glioblastoma multiforme: concepts and candidates. Cancer J 18(1):69\u201381. https:\/\/doi.org\/10.1097\/PPO.0b013e31824671c9","journal-title":"Cancer J"},{"issue":"7","key":"6981_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/v13071294","volume":"13","author":"YR Suryawanshi","year":"2021","unstructured":"Suryawanshi YR, Schulze AJ (2021) Oncolytic viruses for malignant glioma: on the verge of success? Viruses 13(7):1294. https:\/\/doi.org\/10.3390\/v13071294","journal-title":"Viruses"},{"key":"6981_CR9","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1056\/NEJMoa2202028","volume":"386","author":"J G\u00e1llego P\u00e9rez-Larraya","year":"2022","unstructured":"G\u00e1llego P\u00e9rez-Larraya J, Garcia-Moure M, Labiano S et al (2022) Oncolytic DNX-2401 virus for pediatric diffuse intrinsic pontine glioma. N Engl J Med 386:2471\u20132481. https:\/\/doi.org\/10.1056\/NEJMoa2202028","journal-title":"N Engl J Med"},{"key":"6981_CR10","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1056\/NEJMoa2024947","volume":"384","author":"GK Friedman","year":"2021","unstructured":"Friedman GK, Johnston JM, Bag AK et al (2021) Oncolytic HSV-1 G207 immunovirotherapy for pediatric high-grade gliomas. N Engl J Med 384:1613\u20131622. https:\/\/doi.org\/10.1056\/NEJMoa2024947","journal-title":"N Engl J Med"},{"issue":"4","key":"6981_CR11","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1093\/neuonc\/noy202","volume":"21","author":"MW Kieran","year":"2019","unstructured":"Kieran MW, Goumnerova L, Manley P, Chi SN, Marcus KJ, Manzanera AG, Polanco MLS, Guzik BW, Aguilar-Cordova E, Diaz-Montero CM, DiPatri AJ, Tomita T, Lulla R, Greenspan L, Aguilar LK, Goldman S (2019) Phase I study of gene-mediated cytotoxic immunotherapy with AdV-tk as adjuvant to surgery and radiation for pediatric malignant glioma and recurrent ependymoma. Neuro Oncol 21(4):537\u2013546. https:\/\/doi.org\/10.1093\/neuonc\/noy202","journal-title":"Neuro Oncol"},{"issue":"7","key":"6981_CR12","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/S2352-4642(23)00031-7","volume":"7","author":"EM Thompson","year":"2023","unstructured":"Thompson EM, Landi D, Brown MC, Friedman HS, McLendon R, Herndon JE 2nd, Buckley E, Bolognesi DP, Lipp E, Schroeder K, Becher OJ, Friedman AH, McKay Z, Walter A, Threatt S, Jaggers D, Desjardins A, Gromeier M, Bigner DD, Ashley DM (2023) Recombinant polio-rhinovirus immunotherapy for recurrent paediatric high-grade glioma: a phase 1b trial. Lancet Child Adolesc Health 7(7):471\u2013478. https:\/\/doi.org\/10.1016\/S2352-4642(23)00031-7","journal-title":"Lancet Child Adolesc Health"},{"issue":"1","key":"6981_CR13","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.232654","volume":"312","author":"RA Sheth","year":"2024","unstructured":"Sheth RA, Wehrenberg-Klee E, Patel SP, Brock KK, Fotiadis N, de Ba\u00e8re T (2024) Intratumoral injection of immunotherapeutics: state of the art and future directions. Radiology 312(1):e232654","journal-title":"Radiology"},{"issue":"4","key":"6981_CR14","doi-asserted-by":"publisher","first-page":"544","DOI":"10.7150\/jca.81793","volume":"14","author":"V Mori","year":"2023","unstructured":"Mori V, DuComb EA, Wagner S, Khan F, Bates JH, Kinsey CM (2023) Visualizing intratumoral injections in lung tumors by endobronchial ultrasound. J Cancer 14(4):544","journal-title":"J Cancer"},{"issue":"5","key":"6981_CR15","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1039\/D2BM01534J","volume":"11","author":"Y Wang","year":"2023","unstructured":"Wang Y, Bastiancich C, Newland B (2023) Injectable local drug delivery systems for glioblastoma: a systematic review and meta-analysis of progress to date. Biomater Sci 11(5):1553\u20131566","journal-title":"Biomater Sci"},{"issue":"8","key":"6981_CR16","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1007\/s11912-023-01422-4","volume":"25","author":"M Ghosn","year":"2023","unstructured":"Ghosn M, Tselikas L, Champiat S, Deschamps F, Bonnet B, Carre \u00c9, Testan M, Danlos FX, Farhane S, Susini S, Suzzoni S (2023) Intratumoral immunotherapy: is it ready for prime time? Curr Oncol Rep 25(8):857\u2013867","journal-title":"Curr Oncol Rep"},{"issue":"2","key":"6981_CR17","doi-asserted-by":"publisher","first-page":"84","DOI":"10.36401\/JIPO-22-8","volume":"6","author":"S Brito-Orama","year":"2023","unstructured":"Brito-Orama S, Sheth RA (2023) The contemporary landscape and future directions of intratumoral immunotherapy. J Immunotherapy Precision Oncol 6(2):84\u201390","journal-title":"J Immunotherapy Precision Oncol"},{"key":"6981_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2022.114505","volume":"189","author":"A Som","year":"2022","unstructured":"Som A, Rosenboom JG, Chandler A, Sheth RA, Wehrenberg-Klee E (2022) Image-guided intratumoral immunotherapy: developing a clinically practical technology. Adv Drug Deliv Rev 189:114505. https:\/\/doi.org\/10.1016\/j.addr.2022.114505","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"6981_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33599-w","volume":"13","author":"EM Kennedy","year":"2022","unstructured":"Kennedy EM, Denslow A, Hewett J, Kong L, De Almeida A, Bryant JD, Lee JS, Jacques J, Feau S, Hayes M, McMichael EL, Wambua D, Farkaly T, Rahmeh AA, Herschelman L, Douglas D, Spinale J, Adhikari S, Deterling J, Scott M, Haines BB, Finer MH, Ashburn TT, Qu\u00e9va C, Lerner L (2022) Development of intravenously administered synthetic RNA virus immunotherapy for the treatment of cancer. Nat Commun 13(1):5907. https:\/\/doi.org\/10.1038\/s41467-022-33599-w","journal-title":"Nat Commun"},{"issue":"6","key":"6981_CR20","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1038\/s41591-023-02347-y","volume":"29","author":"F Nassiri","year":"2023","unstructured":"Nassiri F, Patil V, Yefet LS, Singh O, Liu J, Dang RM, Yamaguchi TN, Daras M, Cloughesy TF, Colman H, Kumthekar PU, Chen CC, Aiken R, Groves MD, Ong SS, Ramakrishna R, Vogelbaum MA, Khagi S, Kaley T, Dang RMA, Melear JM, Peereboom DM, Rodriguez A, Yankelevich M, Nair SG, Puduvalli VK, Aldape K, Gao A, L\u00f3pez-Janeiro \u00c1, de Andrea CE, Alonso MM, Boutros P, Robbins J, Mason WP, Sonabend AM, Stupp R, Fueyo J, Gomez-Manzano C, Lang FF, Zadeh G (2023) Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1\/2 trial. Nat Med 29(6):1370\u20131378. https:\/\/doi.org\/10.1038\/s41591-023-02347-y","journal-title":"Nat Med"},{"key":"6981_CR21","doi-asserted-by":"publisher","unstructured":"Gao P, Ding G, Wang L (2021) The efficacy and safety of oncolytic viruses in the treatment of intermediate to advanced solid tumors: a systematic review and meta-analysis. Transl Cancer Res 10(10):4290\u20134302. https:\/\/doi.org\/10.21037\/tcr-21-905","DOI":"10.21037\/tcr-21-905"},{"key":"6981_CR22","doi-asserted-by":"publisher","first-page":"4119","DOI":"10.1038\/s41467-022-31262-y","volume":"13","author":"T Todo","year":"2022","unstructured":"Todo T, Ino Y, Ohtsu H, Shibahara J, Tanaka M (2022) A phase I\/II study of triple-mutated oncolytic herpes virus G47\u2206 in patients with progressive glioblastoma. Nat Commun 13:4119. https:\/\/doi.org\/10.1038\/s41467-022-31262-y","journal-title":"Nat Commun"},{"key":"6981_CR23","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.3389\/fonc.2019.01182","volume":"9","author":"M Abudoureyimu","year":"2019","unstructured":"Abudoureyimu M, Lai Y, Tian C, Wang T, Wang R, Chu X (2019) Oncolytic adenovirus\u2014a nova for gene-targeted oncolytic viral therapy in HCC. Front Oncol 9:1182. https:\/\/doi.org\/10.3389\/fonc.2019.01182","journal-title":"Front Oncol"},{"key":"6981_CR24","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1716435","author":"A Desjardins","year":"2018","unstructured":"Desjardins A, Gromeier M, Herndon JE 2nd, Beaubier N, Bolognesi DP, Friedman AH, Friedman HS, McSherry F, Muscat AM, Nair S, Peters KB, Randazzo D, Sampson JH, Vlahovic G, Harrison WT, McLendon RE, Ashley D, Bigner DD (2018) Recurrent glioblastoma treated with recombinant poliovirus. N Engl J Med. https:\/\/doi.org\/10.1056\/NEJMoa1716435","journal-title":"N Engl J Med"},{"key":"6981_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216169","volume":"562","author":"QT Storozynsky","year":"2023","unstructured":"Storozynsky QT, Agopsowicz KC, Noyce RS, Bukhari AB, Han X, Snyder N, Umer BA, Gamper AM, Godbout R, Evans DH, Hitt MM (2023) Radiation combined with oncolytic vaccinia virus provides pronounced antitumor efficacy and induces immune protection in an aggressive glioblastoma model. Cancer Lett 562:216169. https:\/\/doi.org\/10.1016\/j.canlet.2023.216169","journal-title":"Cancer Lett"},{"key":"6981_CR26","unstructured":"Amjad MT, Chidharla A, Kasi A (2023) Cancer chemotherapy. In: StatPearls [Internet]. Treasure Island, StatPearls Publishing. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK564367\/. Accessed Jan 2025"},{"key":"6981_CR27","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2017-CT027","volume":"77","author":"MM Alonso","year":"2017","unstructured":"Alonso MM, Garc\u00eda-Moure M, Gonzalez-Huarriz M, Marigil M, Hernandez-Alcoceba R, Bu\u00f1ales M, Herv\u00e1s S, Gallego J, Gomez-Manzano C, Fueyo J, Lang F, Peterkin J, Diez-Valle R, Tejada S (2017) Abstract CT027: oncolytic virus DNX-2401 with a short course of temozolomide for glioblastoma at first recurrence: clinical data and prognostic biomarkers. Cancer Res 77:CT027. https:\/\/doi.org\/10.1158\/1538-7445.AM2017-CT027","journal-title":"Cancer Res"},{"issue":"6","key":"6981_CR28","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1007\/s13311-022-01256-1","volume":"19","author":"ML Shoaf","year":"2022","unstructured":"Shoaf ML, Desjardins A (2022) Oncolytic viral therapy for malignant glioma and their application in clinical practice. Neurotherapeutics 19(6):1818. https:\/\/doi.org\/10.1007\/s13311-022-01256-1","journal-title":"Neurotherapeutics"},{"issue":"4","key":"6981_CR29","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1158\/2326-6066.CIR-14-0015","volume":"2","author":"EA Chiocca","year":"2014","unstructured":"Chiocca EA, Rabkin SD (2014) Oncolytic viruses and their application to cancer immunotherapy. Cancer Immunol Res 2(4):295\u2013300. https:\/\/doi.org\/10.1158\/2326-6066.CIR-14-0015","journal-title":"Cancer Immunol Res"},{"issue":"7","key":"6981_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15071947","volume":"23","author":"A Gryciuk","year":"2023","unstructured":"Gryciuk A, Rogalska M, Baran J, Kuryk L, Staniszewska M (2023) Oncolytic adenoviruses armed with co-stimulatory molecules for cancer treatment. Cancers (Basel) 23(7):1947. https:\/\/doi.org\/10.3390\/cancers15071947","journal-title":"Cancers (Basel)"}],"container-title":["Child's Nervous System"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00381-025-06981-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00381-025-06981-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00381-025-06981-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T13:16:08Z","timestamp":1770815768000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00381-025-06981-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,18]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["6981"],"URL":"https:\/\/doi.org\/10.1007\/s00381-025-06981-4","relation":{},"ISSN":["0256-7040","1433-0350"],"issn-type":[{"value":"0256-7040","type":"print"},{"value":"1433-0350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,18]]},"assertion":[{"value":"11 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study is deemed exempt from receiving ethical approval.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"315"}}